Document is current
Any future updates will be listed below
-
Authors
Mouheb, Agathe
Lambert, Oriane
Alencar de Pinho, Natalia
Jacquelinet, Christian
Laville, Maurice
Combe, Christian
Fouque, Denis
Frimat, Luc
Massy, Ziad A.
Laville, Solène M.
Liabeuf, Sophie https://orcid.org/0000-0001-5384-9006
,
Alencar de Pinho, Natalia
Cannet, Dorothée
Combe, Christian
Fouque, Denis
Frimat, Luc
Hamroun, Aghilès
Herpe, Yves-Edouard
Jacquelinet, Christian
Lambert, Oriane
Lange, Céline
Laville, Maurice
Liabeuf, Sophie https://orcid.org/0000-0001-5384-9006
Massy, Ziad A.
Metzger, Marie
Morel, Pascal
Pascal, Christophe
Pecoits-Filho, Roberto
Schantsra, Joost
Stengel, Bénédicte
Hannedouche, Thierry
Moulin, Bruno
Mailliez, Sébastien
Lebrun, Gaétan
Magnant, Éric
Choukroun, Gabriel
Deroure, Benjamin
Lacraz, Adeline
Lambrey, Guy
Bourdenx, Jean Philippe
Essig, Marie
Lobbedez, Thierry
Azar, Raymond
Sekhri, Hacène
Smati, Mustafa
Jamali, Mohamed
Klein, Alexandre
Delahousse, Michel
Combe, Christian
Martin, Séverine
Landru, Isabelle
Thervet, Eric
Massy, Ziad
Lang, Philippe
Belenfant, Xavier
Urena, Pablo
Vela, Carlos
Frimat, Luc
Chauveau, Dominique
Panescu, Viktor
Noel, Christian
Glowacki, François
Hoffmann, Maxime
Hourmant, Maryvonne
Besnier, Dominique
Testa, Angelo
Kuentz, F.
Zaoui, Philippe
Chazot, Charles
Juillard, Laurent
Burtey, Stéphane
Keller, Adrien
Kamar, N.
Fouque, Denis
Laville, Maurice
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 27 November 2024
First Online: 8 January 2025
Declarations
:
: A.M., S.M.L., S.L., O.L., M.L. have nothing to declare. Z.A.M. reports having received grants for CKD-REIN and other research projects from Amgen, Baxter, Fresenius Medical Care, GlaxoSmithKline, Merck Sharp and Dohme-Chibret, Sanofi-Genzyme, Lilly, Otsuka, AstraZeneca, Vifor and the French government, as well as fees and grants to charities from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline. N.A.P. declares financial support from pharmaceutical companies who are members of the CKD-REIN public–private partnership: Fresenius Medical Care, GlaxoSmithKline, Vifor France, and Boehringer Ingelheim; all grants were made to Paris Saclay University. D.F. has received grants and lecture fees from Astellas, GlaxoSmithKline, Dr Schar, Theradial, and AstraZeneca.
: The study protocol was approved by the institutional review board at the French National Institute of Health and medical research (INSERM; reference: IRB00003888).
: This article does not contain any studies with animals.
: Patients provided informed consent to participate.
